Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioNature
Tel Aviv, Israelbionature.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BioNature is a biotechnology company dedicated to the development of innovative peptide-based drugs for the treatment of neurodegenerative diseases. The company's core technology, the BNP (BioNature Peptides) platform, enables the creation of chimeric peptides designed to cross the blood-brain barrier and activate neuroprotective pathways. Their primary focus includes conditions such as Amyotrophic Lateral Sclerosis (ALS), Alzheimer's, and Parkinson's disease. By targeting receptors like IGF-1 and GLP-1, BioNature seeks to provide disease-modifying therapies that address the underlying mechanisms of neuronal loss. The company's lead candidate, BNP-1, has shown promise in preclinical models of ALS by promoting neuronal survival and reducing neuroinflammation. BioNature operates as a private entity, leveraging intellectual property developed at Tel Aviv University to advance its pipeline of neuroprotective agents.
- Therapeutic areas
- Neurology
- Modalities
- Peptides
- Industry
- Biotech
Beyond the preview
Go deeper on BioNature.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioNature.